The latest report published by IMARC Group, titled “Animal Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on animal vaccine market size. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global animal vaccine market size reached US$ 13.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 25.1 Billion by 2032, exhibiting a growth rate (CAGR) of 7.24% during 2024-2032.

An animal vaccine is a biological preparation that improves immunity to a particular disease. It operates by stimulating the immune system to identify and destroy specific pathogens. It contains agents that resemble the disease-causing organism and are usually manufactured from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. When administered to animals, these vaccines prompt the immune system to recognize the antigens associated with the pathogen as foreign, subsequently creating an immune response. This process establishes a memory within the immune system, enabling it to recognize and swiftly neutralize the actual pathogen if encountered in the future. Animal vaccines play a pivotal role in preventing the spread of infectious diseases within animal populations, contributing to improved overall animal health and welfare.       

Request to Get the Sample Report: https://www.imarcgroup.com/animal-vaccine-market/requestsample

Market Trends:

The global animal vaccine market is primarily driven by the increasing prevalence of various infectious diseases among animals. Moreover, the rising focus on animal welfare and the growing adoption of companion animals have augmented the need for advanced vaccination programs to ensure their well-being, thereby bolstering market expansion. Additionally, the implementation of stringent regulations by regulatory bodies, emphasizing the significance of immunization to prevent the spread of zoonotic diseases, has significantly catalyzed the market. Furthermore, the escalating demand for livestock products, coupled with the rising awareness regarding the benefits of vaccination in livestock management, has further fueled the growth of the animal vaccine market. Continual technological advancements in vaccine development, such as the utilization of recombinant DNA technology and adjuvants, have also positively impacted the market, enabling the production of more efficient and specific vaccines.

Explore Full Report with Table of Contents: https://www.imarcgroup.com/animal-vaccine-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• H. Boehringer Sohn AG & Co. KG
• Ceva Sante Animale
• Elanco Animal Health Incorporated (Eli Lilly and Company)
• Hester Biosciences Limited
• Hipra S.A.
• Hygieia Biological Laboratories
• Merck & Co. Inc.
• Phibro Animal Health Corporation
• Vaxxinova GmbH (EW Group)
• Virbae
• Zoetis Services LLC

Animal Vaccine Market Segmentation:

Our report has categorized the market based on region, product, animal type, route of administration.

Breakup by Product:

• Attenuated vaccines
• Inactivated vaccines
• Subunit vaccines
• Toxoid vaccines
• Conjugate vaccines
• Recombinant vaccines
• DNA vaccines Type

Breakup by Animal Type:

• Companion animal  
  • Dogs
  • Cats
• Livestock animal  
  • Cattle
  • Pigs
  • Poultry
  • Sheep
  • Others
• Aquaculture

Breakup by Route of Administration:

• Subcutaneous
• Intramuscular
• Intranasal
• Others

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163